The efficiency and safety of Triple-drug combination of albumin-bound | CMAR User WalkingHorse, in the LungCancerSupport subreddit, 14 Aug 2024
The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study User montaukwhaler, in the non small cell lung cancer subreddit, 13 Aug 2024